STEP-DOWN APPROACH IN METHOTREXATE USE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (STEMETRA): A PILOT STUDY DEMONSTRATING EFFICACY AND SAFETY OF SHORT-TERM HIGH DOSE METHOTREXATE

被引：0
|
作者：
Pendolino, M. [1 ]
Serban, T. [1 ]
Camellino, D. [1 ]
Diana, P. [1 ]
Giusti, A. [1 ]
Bianchi, G. [1 ]
机构：
[1] ASL3 Genovese, SC Reumatol, Sci Med, Genoa, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Disease-modifying drugs (DMARDs);
D O I：
10.1136/annrheumdis-2023-eular.5648
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0499
引用
收藏
页码：1444 / 1445
页数：2
相关论文
共 50 条
  • [41] Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors
    Naniwa, Taio
    Iwagaitsu, Shiho
    Kajiura, Mikiko
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (03) : 673 - 687
  • [42] An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab
    Sidiropoulos, PI
    Siakka, P
    Raptopoulou, A
    Mamoulaki, M
    Choulaki, C
    Koutala, H
    Kouroumali, H
    Kritikos, H
    Boumpas, DT
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (04) : 538 - 541
  • [43] IMPAIRED POLYGLUTAMYLATION OF METHOTREXATE AS A CAUSE OF RESISTANCE IN CCRF-CEM CELLS AFTER SHORT-TERM, HIGH-DOSE TREATMENT WITH THIS DRUG
    PIZZORNO, G
    MINI, E
    CORONNELLO, M
    MCGUIRE, JJ
    MOROSON, BA
    CASHMORE, AR
    DREYER, RN
    LIN, JT
    MAZZEI, T
    PERITI, P
    BERTINO, JR
    CANCER RESEARCH, 1988, 48 (08) : 2149 - 2155
  • [44] LONG-TERM PROSPECTIVE-STUDY OF THE USE OF METHOTREXATE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - UPDATE AFTER A MEAN OF 90 MONTHS
    KREMER, JM
    PHELPS, CT
    ARTHRITIS AND RHEUMATISM, 1992, 35 (02): : 138 - 145
  • [45] A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate
    Smolen, Josef S.
    Agarwal, Sandeep K.
    Ilivanova, Elena
    Xu, Xie Lillian
    Miao, Ye
    Zhuang, Yanli
    Nnane, Ivo
    Radziszewski, Waldemar
    Greenspan, Andrew
    Beutler, Anna
    Baker, Daniel
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (05) : 831 - 839
  • [46] A prospective randomised comparative study of the short-term effects of infliximab (remicade) and intravenous pulse methylprednisolone in rheumatoid arthritis patients with active disease despite methotrexate
    Durez, P
    Toukap, AN
    Lauwerys, BR
    Westhovens, R
    Houssiau, FA
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 173 - 174
  • [47] Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan
    Tanaka, Yoshiya
    Mimori, Tsuneyo
    Yamanaka, Hisashi
    Sunaga, Naomi
    Morita, Kazuo
    Kimura, Junko
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2020, 30 (03) : 424 - 433
  • [48] The efficacy and safety of Adalimunab (Humira®) plus Methotrexate vs. Adalimumab alone or methotrexate alone in the early treatment of rheumatoid arthritis (RA):: 1-and 2-year results of the premier study
    Breedveld, FC
    Weisman, MH
    Kavanaugh, AF
    Cohen, SB
    Pavelka, K
    Van Vollenhoven, R
    Perez, JL
    Spencer-Green, GT
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 60 - 60
  • [49] A Randomized Placebo-Controlled Phase 2 Study To Evaluate Efficacy, Safety and Tolerability Of Two Secukinumab Loading Dose Regimens In Subjects With Active Rheumatoid Arthritis Despite Treatment With Methotrexate
    Adami, Silvano
    Beaulieu, Andre
    Rahman, Proton
    Seriolo, Bruno
    Lee, Janet S.
    Krammer, Gerhard
    Porter, Brian
    Thulasiraman, Anuradha
    Richards, Hanno B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S220 - S220
  • [50] REAL-WORLD HAWK STUDY: LONG-TERM SAFETY AND EFFECTIVENESS OF ADALIMUMAB WITH HIGHER-DOSE METHOTREXATE IN JAPANESE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Tanaka, Y.
    Mimori, T.
    Yamanaka, H.
    Nakajima, R.
    Morita, K.
    Kimura, J.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 561 - 562
12345